These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9724909)

  • 1. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.
    Minko T; Kopecková P; Pozharov V; Kopecek J
    J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line.
    Minko T; Kopecková P; Kopecek J
    J Control Release; 1999 May; 59(2):133-48. PubMed ID: 10332049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.
    Kunath K; Kopecková P; Minko T; Kopecek J
    Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
    Omelyanenko V; Kopecková P; Gentry C; Kopecek J
    J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.
    Tijerina M; Fowers KD; Kopecková P; Kopecek J
    Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.
    Minko T; Kopecková P; Kopecek J
    Pharm Res; 1999 Jul; 16(7):986-96. PubMed ID: 10450921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
    Omelyanenko V; Gentry C; Kopecková P; Kopecek J
    Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
    Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
    Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
    Tijerina M; Kopecková P; Kopecek J
    Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
    Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
    Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells.
    Demoy M; Minko T; Kopecková P; Kopecek J
    J Control Release; 2000 Oct; 69(1):185-96. PubMed ID: 11018556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
    Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
    Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.
    Fowers KD; Kopeček J
    Macromol Biosci; 2012 Apr; 12(4):502-14. PubMed ID: 22278817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates.
    Kasuya Y; Lu ZR; Kopecková P; Minko T; Tabibi SE; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):203-11. PubMed ID: 11489496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells.
    Wang F; Jiang X; Yang DC; Elliott RL; Head JF
    Anticancer Res; 2000; 20(2A):799-808. PubMed ID: 10810357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.
    Minko T; Kopecková P; Kopecek J
    Int J Cancer; 2000 Apr; 86(1):108-17. PubMed ID: 10728603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells.
    Budworth J; Gant TW; Gescher A
    Br J Cancer; 1997; 75(9):1330-5. PubMed ID: 9155054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
    Shiah JJ; Sun Y; Peterson CM; Kopecek J
    J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.